Cargando…

EphA2 affects the sensitivity of oxaliplatin by inducing EMT in oxaliplatin-resistant gastric cancer cells

Erythropoietin-producing hepatocellular receptor A2 (EphA2) is upregulated in gastric cancer tissues and cells, which is accompanied by epithelial–mesenchymal transition (EMT). The current study was designed to establish the oxaliplatin-resistant human gastric cancer cell line SGC-7901/L-OHP, to det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Qiaocheng, Chen, Zihua, Chen, Zhikang, Chen, Jinxiang, Wang, Ran, Huang, Changhao, Yuan, Weijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564621/ https://www.ncbi.nlm.nih.gov/pubmed/28624791 http://dx.doi.org/10.18632/oncotarget.18208

Ejemplares similares

EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis
por: Mao, Linfeng, et al.
Publicado: (2021)

Correction to: EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis
por: Mao, Linfeng, et al.
Publicado: (2022)

EphA2 promotes tumorigenicity of cervical cancer by up‐regulating CDK6
por: Huang, Changhao, et al.
Publicado: (2021)

miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer
por: Huang, Jin, et al.
Publicado: (2017)

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

The relationship between miR-302b and EphA2 and their clinical significance in gastric cancer
por: Tang, Lanhua, et al.
Publicado: (2018)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

EphA4 is a prognostic factor in gastric cancer
por: Miyazaki, Kohji, et al.
Publicado: (2013)

Puerarin inhibits EMT induced by oxaliplatin via targeting carbonic anhydrase XII
por: Chen, Xindong, et al.
Publicado: (2022)

miR-135a promotes gastric cancer progression and resistance to oxaliplatin
por: Yan, Lin-Hai, et al.
Publicado: (2016)

Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro
por: Zhao, Qun, et al.
Publicado: (2010)

Connexin 32 downregulation is critical for chemoresistance in oxaliplatin-resistant HCC cells associated with EMT
por: Yang, Yan, et al.
Publicado: (2019)

Metastatic squamous cell carcinoma from hand skin causing small bowel obstruction: an unusual case presentation
por: Li, Ruixin, et al.
Publicado: (2014)

Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil
por: Chen, C-C, et al.
Publicado: (2007)

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

JUNB mediates oxaliplatin resistance via the MAPK signaling pathway in gastric cancer by chromatin accessibility and transcriptomic analysis: JUNB mediates oxaliplatin resistance in gastric cancer
por: Li, Suyao, et al.
Publicado: (2023)

Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling
por: Gao, Zicong, et al.
Publicado: (2021)

AT-rich interactive domain1A determines sensitivity to oxaliplatin in gastric cancer cells
por: Liu, Qing, et al.
Publicado: (2020)

Roles of EphA2 in Development and Disease
por: Park, Jeong Eun, et al.
Publicado: (2013)

Upregulation of Autophagy-Related Gene-5 (ATG-5) Is Associated with Chemoresistance in Human Gastric Cancer
por: Ge, Jie, et al.
Publicado: (2014)

Oxaliplatin-Induced Lhermitte's Sign in Gastric Cancer
por: Okamoto, Takeshi, et al.
Publicado: (2020)

Oxaliplatin in practice.
por: Misset, J. L.
Publicado: (1998)

The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
por: Shin, Jae Min, et al.
Publicado: (2023)

Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients
por: Dai, Xichao, et al.
Publicado: (2016)

PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway
por: Li, Huafu, et al.
Publicado: (2021)

β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1
por: Li, Xiaoqiang, et al.
Publicado: (2016)

Oxaliplatin-induced Evan's syndrome
por: Earle, C C, et al.
Publicado: (2001)

The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma
por: Deng, Ganlu, et al.
Publicado: (2017)

Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
por: Sun, Wei, et al.
Publicado: (2021)

EphA2 bears plasticity to tumor invasion
por: Sugiyama, Nami, et al.
Publicado: (2013)

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation
por: Barquilla, Antonio, et al.
Publicado: (2016)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

EphA2 Affects Development of the Eye Lens Nucleus and the Gradient of Refractive Index
por: Cheng, Catherine, et al.
Publicado: (2022)

EphA2 Promotes the Development of Cervical Cancer through the CXCL11/PD-L1 Pathway
por: Zhao, Xinyue, et al.
Publicado: (2022)

Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
por: Gonçalves-Ribeiro, Samuel, et al.
Publicado: (2016)

A Novel Occulta-Type Spina Bifida Mediated by Murine Double Heterozygotes EphA2 and EphA4 Receptor Tyrosine Kinases
por: Abdullah, Nor Linda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j37oj32c3k3m75gp7mku9bvdns